Date published: 2026-4-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

NUDT19 Inhibitors

NUDT19 inhibitors are a class of chemical compounds designed to specifically target the NUDT19 protein, which is a member of the Nudix hydrolase family. NUDT19 enzymes are involved in the hydrolysis of CoA (coenzyme A) derivatives, playing a crucial role in maintaining the balance of CoA and its derivatives within cells. This balance is vital for various metabolic processes, including fatty acid synthesis, energy production, and the regulation of metabolic intermediates. Inhibitors of NUDT19 are designed to bind to the enzyme, blocking its activity and preventing the hydrolysis of CoA derivatives. This inhibition can lead to alterations in cellular metabolism, particularly in pathways where CoA and its derivatives are essential. Understanding how NUDT19 inhibitors function is important for elucidating the specific biochemical roles of this enzyme and how it contributes to broader metabolic networks within the cell. The chemical nature of NUDT19 inhibitors can vary, reflecting differences in their binding mechanisms and specificity. Some inhibitors may act as competitive antagonists, binding directly to the active site of NUDT19 and competing with its natural substrates, such as CoA derivatives. This type of inhibition directly blocks the enzyme's catalytic activity, preventing the conversion of CoA derivatives into their corresponding products. Other inhibitors might function allosterically, binding to different regions of the enzyme and inducing conformational changes that reduce its activity or alter its interactions with substrates. The development of NUDT19 inhibitors typically involves advanced structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and molecular modeling. These methods help identify critical binding sites on NUDT19 and optimize the interactions between the inhibitors and the enzyme to enhance their selectivity and potency. Researchers focus on creating inhibitors that are highly selective for NUDT19, minimizing off-target effects on other Nudix hydrolases or related enzymes involved in CoA metabolism. Through the study of NUDT19 inhibitors, scientists aim to gain a deeper understanding of the enzyme's role in cellular metabolism and how its modulation can influence various biochemical pathways related to CoA and its derivatives.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Entinostat is a HDAC inhibitor that can repress MSL-1 by inducing histone modifications, thereby altering its binding affinity to chromatin.

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
$265.00
$944.00
5
(1)

A p300 inhibitor, C646 can interfere with MSL-1 if it functions in transcriptional elongation processes facilitated by the p300 protein.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor Olaparib can impact DNA repair processes where MSL-1 may function, therefore leading to reduced protein stability.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

NEDD8-activating enzyme inhibitor MLN4924 can influence ubiquitin-proteasome pathways affecting the degradation of MSL-1.

3-[(3-Methoxybenzoyl)amino]-4-(4-methyl-1-piperazinyl)benzoic acid methyl ester-d3

890190-22-4 (unlabeled)sc-484812
1 mg
$380.00
(0)

WDR5 inhibitor WDR5-0103 interferes with chromatin remodeling complexes that involve MSL-1, hence affecting its role.

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

BET bromodomain inhibitor I-BET151 can restrict MSL-1 function by modulating the recruitment of elongation factors.

UNC1999

1431612-23-5sc-475314
5 mg
$142.00
1
(0)

EZH2 inhibitor UNC1999 can impact MSL-1 if it is involved in PRC2-mediated gene silencing.

BIX01294 hydrochloride

1392399-03-9sc-293525
sc-293525A
sc-293525B
1 mg
5 mg
25 mg
$37.00
$112.00
$408.00
(1)

G9a inhibitor BIX-01294 can influence MSL-1 by altering methylation states of histones with which MSL-1 interacts.

PFI-1

1403764-72-6sc-478504
5 mg
$98.00
(0)

BET bromodomain inhibitor PFI-1 can affect MSL-1 by modifying elongation factor recruitment in transcription.

RVX 208

1044870-39-4sc-472700
10 mg
$340.00
(0)

BET inhibitor RVX-208 can modulate MSL-1 activity by affecting BRD4 recruitment in chromatin remodeling.